Browsing byAuthorUyl-de Groot, CA
Showing results 1 to 5 of 5
Issue Date | Title | Author(s) |
2017-04-01 | Balancing the Optimal and the Feasible: A Practical Guide for Setting Up Patient Registries for the Collection of Real-World Data for Health Care Decision Making Based on Dutch Experiences | de Groot, S; van der Linden, N; Franken, MG; Blommestein, HM; Leeneman, B; van Rooijen, E; Koos van der Hoeven, JJM; Wouters, MW; Westgeest, HM; Uyl-de Groot, CA |
2016-01-01 | Costs of non-small cell lung cancer in the Netherlands | van der Linden, N; Bongers, ML; Coupé, VMH; Smit, EF; Groen, HJM; Welling, A; Schramel, FMNH; Uyl-de Groot, CA |
2019-03-01 | Determining the Comparative Value of Pharmaceutical Risk-Sharing Policies in Non–Small Cell Lung Cancer Using Real-World Data | Holleman, MS; Uyl-de Groot, CA; Goodall, S; van der Linden, N |
2017-09-01 | Treatment Patterns and Differences in Survival of Non-Small Cell Lung Cancer Patients Between Academic and Non-Academic Hospitals in the Netherlands | van der Linden, N; Bongers, ML; Coupé, VMH; Smit, EF; Groen, HJM; Welling, A; Schramel, FMNH; Uyl-de Groot, CA |
2016-02-01 | Treatments and costs for recurrent and/or metastatic squamous cell carcinoma of the head and neck in the Netherlands | van der Linden, N; Buter, J; Pescott, CP; Lalisang, RI; de Boer, JP; de Graeff, A; van Herpen, CML; Baatenburg de Jong, RJ; Uyl-de Groot, CA |